Related Experiment Video
Updated: Jul 7, 2025
06:08
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.2K
COVID-19: From emerging variants to vaccination
Thilini H Senevirathne1, Demi Wekking2, Joseph W R Swain3
1Faculty of Science, Katholieke Universiteit Leuven, Kasteelpark Arenberg, Leuven, Belgium.
Cytokine & Growth Factor Reviews
|December 22, 2023
Summary
The SARS-CoV-2 virus evolves through mutations, creating variants of concern (VOC). This review examines VOC evolution and vaccination strategies to combat COVID-19, emphasizing vaccine effectiveness against severe disease.
Area of Science:
- Virology
- Epidemiology
- Immunology
Background:
- The SARS-CoV-2 pandemic has caused widespread global health and socioeconomic disruption.
- Viral evolution through mutations leads to the emergence of variants of interest (VOI) and variants of concern (VOC).
- These variants pose risks due to increased transmissibility, severity, immune escape, and reduced effectiveness of countermeasures.
Purpose of the Study:
- To provide a comprehensive overview of the COVID-19 pandemic.
- To focus on the evolution of SARS-CoV-2 variants of concern (VOC).
- To review vaccination strategies developed against these evolving variants.
Main Methods:
- Literature review of scientific publications on SARS-CoV-2 evolution.
- Analysis of data on the characteristics and impact of VOCs.
- Examination of COVID-19 vaccine development and efficacy studies.
Main Results:
- SARS-CoV-2 has continuously evolved, with variants like Omicron and its subvariants remaining prevalent.
- Despite viral evolution, current COVID-19 vaccines demonstrate continued effectiveness in preventing severe illness, hospitalization, and death.
- Some variants exhibit increased resistance to vaccines and treatments, necessitating ongoing research.
Conclusions:
- Understanding the evolution of SARS-CoV-2 variants of concern is crucial for public health.
- Vaccination remains a cornerstone strategy for mitigating the impact of COVID-19.
- Continued surveillance and adaptation of vaccines and therapeutics are essential to address emerging variants.
Related Concept Videos
01:51Vaccinations
44.5K
Overview
44.5K
01:30Cancer Vaccines
370
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370
00:42Cross-reactivity
31.1K
Overview
31.1K
00:36Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
00:57Viral Recombination
23.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K
01:05Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K